Repligen (RGEN) Tops Q1 EPS by 10c ; Offers Guidance
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $180.29 +2.23%
Financial Fact:
Net (loss) income: 1.16M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Net (loss) income: 1.16M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q1 EPS of $0.48, $0.10 better than the analyst estimate of $0.38. Revenue for the quarter came in at $194 million versus the consensus estimate of $192.05 million.
GUIDANCE:
Repligen sees FY2026 EPS of $1.97-$2.05, versus the consensus of $1.97.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup set to join top banks in Anthropic IPO - Bloomberg
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
